Global Peptide-PMO Conjugates (PPMO) Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Peptide-PMO Conjugates (PPMO) Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Peptide-PMO Conjugates (PPMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 CPP-PMO
  • 1.2.3 Targeting Peptide-PMO
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Peptide-PMO Conjugates (PPMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Drug Delivery
  • 1.3.3 Gene Therapy
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Peptide-PMO Conjugates (PPMO) Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Region
  • 2.2.1 Global Peptide-PMO Conjugates (PPMO) Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2024)
  • 2.2.3 Global Peptide-PMO Conjugates (PPMO) Revenue by Region (2025-2030)
  • 2.2.4 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2019-2030)
• 2.3 Global Peptide-PMO Conjugates (PPMO) Sales Estimates and Forecasts 2019-2030
• 2.4 Global Peptide-PMO Conjugates (PPMO) Sales by Region
  • 2.4.1 Global Peptide-PMO Conjugates (PPMO) Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2024)
  • 2.4.3 Global Peptide-PMO Conjugates (PPMO) Sales by Region (2025-2030)
  • 2.4.4 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Peptide-PMO Conjugates (PPMO) Sales by Manufacturers
  • 3.1.1 Global Peptide-PMO Conjugates (PPMO) Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide-PMO Conjugates (PPMO) in 2023
• 3.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Manufacturers
  • 3.2.1 Global Peptide-PMO Conjugates (PPMO) Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Peptide-PMO Conjugates (PPMO) Revenue in 2023
• 3.3 Global Key Players of Peptide-PMO Conjugates (PPMO), Industry Ranking, 2021 VS 2022
• 3.4 Global Peptide-PMO Conjugates (PPMO) Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Peptide-PMO Conjugates (PPMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Product Offered and Application
• 3.8 Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Peptide-PMO Conjugates (PPMO) Sales by Type
  • 4.1.1 Global Peptide-PMO Conjugates (PPMO) Historical Sales by Type (2019-2024)
  • 4.1.2 Global Peptide-PMO Conjugates (PPMO) Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)
• 4.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Type
  • 4.2.1 Global Peptide-PMO Conjugates (PPMO) Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Peptide-PMO Conjugates (PPMO) Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)
• 4.3 Global Peptide-PMO Conjugates (PPMO) Price by Type
  • 4.3.1 Global Peptide-PMO Conjugates (PPMO) Price by Type (2019-2024)
  • 4.3.2 Global Peptide-PMO Conjugates (PPMO) Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Peptide-PMO Conjugates (PPMO) Sales by Application
  • 5.1.1 Global Peptide-PMO Conjugates (PPMO) Historical Sales by Application (2019-2024)
  • 5.1.2 Global Peptide-PMO Conjugates (PPMO) Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)
• 5.2 Global Peptide-PMO Conjugates (PPMO) Revenue by Application
  • 5.2.1 Global Peptide-PMO Conjugates (PPMO) Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Peptide-PMO Conjugates (PPMO) Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)
• 5.3 Global Peptide-PMO Conjugates (PPMO) Price by Application
  • 5.3.1 Global Peptide-PMO Conjugates (PPMO) Price by Application (2019-2024)
  • 5.3.2 Global Peptide-PMO Conjugates (PPMO) Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Peptide-PMO Conjugates (PPMO) Market Size by Type
  • 6.1.1 US & Canada Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2030)
  • 6.1.2 US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2030)
• 6.2 US & Canada Peptide-PMO Conjugates (PPMO) Market Size by Application
  • 6.2.1 US & Canada Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2030)
  • 6.2.2 US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2030)
• 6.3 US & Canada Peptide-PMO Conjugates (PPMO) Market Size by Country
  • 6.3.1 US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Peptide-PMO Conjugates (PPMO) Market Size by Type
  • 7.1.1 Europe Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2030)
  • 7.1.2 Europe Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2030)
• 7.2 Europe Peptide-PMO Conjugates (PPMO) Market Size by Application
  • 7.2.1 Europe Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2030)
  • 7.2.2 Europe Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2030)
• 7.3 Europe Peptide-PMO Conjugates (PPMO) Market Size by Country
  • 7.3.1 Europe Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2030)
  • 7.3.3 Europe Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Peptide-PMO Conjugates (PPMO) Market Size by Type
  • 8.1.1 China Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2030)
  • 8.1.2 China Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2030)
• 8.2 China Peptide-PMO Conjugates (PPMO) Market Size by Application
  • 8.2.1 China Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2030)
  • 8.2.2 China Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Peptide-PMO Conjugates (PPMO) Market Size by Type
  • 9.1.1 Asia Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2030)
  • 9.1.2 Asia Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2030)
• 9.2 Asia Peptide-PMO Conjugates (PPMO) Market Size by Application
  • 9.2.1 Asia Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2030)
  • 9.2.2 Asia Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2030)
• 9.3 Asia Peptide-PMO Conjugates (PPMO) Market Size by Region
  • 9.3.1 Asia Peptide-PMO Conjugates (PPMO) Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2030)
  • 9.3.3 Asia Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 WuXi AppTec
  • 11.1.1 WuXi AppTec Company Information
  • 11.1.2 WuXi AppTec Overview
  • 11.1.3 WuXi AppTec Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 WuXi AppTec Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 WuXi AppTec Recent Developments
• 11.2 Creative Biogene
  • 11.2.1 Creative Biogene Company Information
  • 11.2.2 Creative Biogene Overview
  • 11.2.3 Creative Biogene Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Creative Biogene Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Creative Biogene Recent Developments
• 11.3 LifeTein
  • 11.3.1 LifeTein Company Information
  • 11.3.2 LifeTein Overview
  • 11.3.3 LifeTein Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 LifeTein Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 LifeTein Recent Developments
• 11.4 Epichem
  • 11.4.1 Epichem Company Information
  • 11.4.2 Epichem Overview
  • 11.4.3 Epichem Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Epichem Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Epichem Recent Developments
• 11.5 Biosynth
  • 11.5.1 Biosynth Company Information
  • 11.5.2 Biosynth Overview
  • 11.5.3 Biosynth Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Biosynth Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Biosynth Recent Developments
• 11.6 PYC Therapeutics
  • 11.6.1 PYC Therapeutics Company Information
  • 11.6.2 PYC Therapeutics Overview
  • 11.6.3 PYC Therapeutics Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 PYC Therapeutics Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 PYC Therapeutics Recent Developments
• 11.7 Asymchem Inc.
  • 11.7.1 Asymchem Inc. Company Information
  • 11.7.2 Asymchem Inc. Overview
  • 11.7.3 Asymchem Inc. Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Asymchem Inc. Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Asymchem Inc. Recent Developments
• 11.8 Ajinomoto
  • 11.8.1 Ajinomoto Company Information
  • 11.8.2 Ajinomoto Overview
  • 11.8.3 Ajinomoto Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Ajinomoto Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Ajinomoto Recent Developments
• 11.9 Sutura
  • 11.9.1 Sutura Company Information
  • 11.9.2 Sutura Overview
  • 11.9.3 Sutura Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Sutura Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Sutura Recent Developments
• 11.10 Hongene Biotech
  • 11.10.1 Hongene Biotech Company Information
  • 11.10.2 Hongene Biotech Overview
  • 11.10.3 Hongene Biotech Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Hongene Biotech Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Hongene Biotech Recent Developments
• 11.11 Sinopep
  • 11.11.1 Sinopep Company Information
  • 11.11.2 Sinopep Overview
  • 11.11.3 Sinopep Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Sinopep Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Sinopep Recent Developments
• 11.12 Veliter
  • 11.12.1 Veliter Company Information
  • 11.12.2 Veliter Overview
  • 11.12.3 Veliter Peptide-PMO Conjugates (PPMO) Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Veliter Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Veliter Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Peptide-PMO Conjugates (PPMO) Industry Chain Analysis
• 12.2 Peptide-PMO Conjugates (PPMO) Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Peptide-PMO Conjugates (PPMO) Production Mode & Process
• 12.4 Peptide-PMO Conjugates (PPMO) Sales and Marketing
  • 12.4.1 Peptide-PMO Conjugates (PPMO) Sales Channels
  • 12.4.2 Peptide-PMO Conjugates (PPMO) Distributors
• 12.5 Peptide-PMO Conjugates (PPMO) Customers

13 Peptide-PMO Conjugates (PPMO) Market Dynamics

• 13.1 Peptide-PMO Conjugates (PPMO) Industry Trends
• 13.2 Peptide-PMO Conjugates (PPMO) Market Drivers
• 13.3 Peptide-PMO Conjugates (PPMO) Market Challenges
• 13.4 Peptide-PMO Conjugates (PPMO) Market Restraints

14 Key Findings in the Global Peptide-PMO Conjugates (PPMO) Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Peptide-PMO Conjugates (PPMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of CPP-PMO

Table 3. Major Manufacturers of Targeting Peptide-PMO

Table 4. Major Manufacturers of Other

Table 5. Global Peptide-PMO Conjugates (PPMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Peptide-PMO Conjugates (PPMO) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Peptide-PMO Conjugates (PPMO) Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2019-2024)

Table 10. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2025-2030)

Table 11. Global Peptide-PMO Conjugates (PPMO) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)

Table 12. Global Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2024) & (Kg)

Table 13. Global Peptide-PMO Conjugates (PPMO) Sales by Region (2025-2030) & (Kg)

Table 14. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2019-2024)

Table 15. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2025-2030)

Table 16. Global Peptide-PMO Conjugates (PPMO) Sales by Manufacturers (2019-2024) & (Kg)

Table 17. Global Peptide-PMO Conjugates (PPMO) Sales Share by Manufacturers (2019-2024)

Table 18. Global Peptide-PMO Conjugates (PPMO) Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Peptide-PMO Conjugates (PPMO), Industry Ranking, 2021 VS 2022 VS 2023

Table 21. Peptide-PMO Conjugates (PPMO) Price by Manufacturers (2019-2024) & (US$/g)

Table 22. Global Peptide-PMO Conjugates (PPMO) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Peptide-PMO Conjugates (PPMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-PMO Conjugates (PPMO) as of 2023)

Table 24. Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Product Offered and Application

Table 26. Global Key Manufacturers of Peptide-PMO Conjugates (PPMO), Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024) & (Kg)

Table 29. Global Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030) & (Kg)

Table 30. Global Peptide-PMO Conjugates (PPMO) Sales Share by Type (2019-2024)

Table 31. Global Peptide-PMO Conjugates (PPMO) Sales Share by Type (2025-2030)

Table 32. Global Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Type (2019-2024)

Table 35. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Type (2025-2030)

Table 36. Peptide-PMO Conjugates (PPMO) Price by Type (2019-2024) & (US$/g)

Table 37. Global Peptide-PMO Conjugates (PPMO) Price Forecast by Type (2025-2030) & (US$/g)

Table 38. Global Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024) & (Kg)

Table 39. Global Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030) & (Kg)

Table 40. Global Peptide-PMO Conjugates (PPMO) Sales Share by Application (2019-2024)

Table 41. Global Peptide-PMO Conjugates (PPMO) Sales Share by Application (2025-2030)

Table 42. Global Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Application (2019-2024)

Table 45. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Application (2025-2030)

Table 46. Peptide-PMO Conjugates (PPMO) Price by Application (2019-2024) & (US$/g)

Table 47. Global Peptide-PMO Conjugates (PPMO) Price Forecast by Application (2025-2030) & (US$/g)

Table 48. US & Canada Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024) & (Kg)

Table 49. US & Canada Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030) & (Kg)

Table 50. US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024) & (Kg)

Table 53. US & Canada Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030) & (Kg)

Table 54. US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Peptide-PMO Conjugates (PPMO) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Peptide-PMO Conjugates (PPMO) Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)

Table 60. US & Canada Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)

Table 61. Europe Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024) & (Kg)

Table 62. Europe Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030) & (Kg)

Table 63. Europe Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024) & (Kg)

Table 66. Europe Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030) & (Kg)

Table 67. Europe Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Peptide-PMO Conjugates (PPMO) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Peptide-PMO Conjugates (PPMO) Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)

Table 73. Europe Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)

Table 74. China Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024) & (Kg)

Table 75. China Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030) & (Kg)

Table 76. China Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024) & (Kg)

Table 79. China Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030) & (Kg)

Table 80. China Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024) & (Kg)

Table 83. Asia Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030) & (Kg)

Table 84. Asia Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024) & (Kg)

Table 87. Asia Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030) & (Kg)

Table 88. Asia Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Peptide-PMO Conjugates (PPMO) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Peptide-PMO Conjugates (PPMO) Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Peptide-PMO Conjugates (PPMO) Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Peptide-PMO Conjugates (PPMO) Sales by Region (2019-2024) & (Kg)

Table 94. Asia Peptide-PMO Conjugates (PPMO) Sales by Region (2025-2030) & (Kg)

Table 95. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Type (2019-2024) & (Kg)

Table 96. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Type (2025-2030) & (Kg)

Table 97. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Application (2019-2024) & (Kg)

Table 100. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Application (2025-2030) & (Kg)

Table 101. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Country (2019-2024) & (Kg)

Table 107. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales by Country (2025-2030) & (Kg)

Table 108. WuXi AppTec Company Information

Table 109. WuXi AppTec Description and Major Businesses

Table 110. WuXi AppTec Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 111. WuXi AppTec Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. WuXi AppTec Recent Developments

Table 113. Creative Biogene Company Information

Table 114. Creative Biogene Description and Major Businesses

Table 115. Creative Biogene Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 116. Creative Biogene Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Creative Biogene Recent Developments

Table 118. LifeTein Company Information

Table 119. LifeTein Description and Major Businesses

Table 120. LifeTein Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 121. LifeTein Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. LifeTein Recent Developments

Table 123. Epichem Company Information

Table 124. Epichem Description and Major Businesses

Table 125. Epichem Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 126. Epichem Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Epichem Recent Developments

Table 128. Biosynth Company Information

Table 129. Biosynth Description and Major Businesses

Table 130. Biosynth Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 131. Biosynth Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Biosynth Recent Developments

Table 133. PYC Therapeutics Company Information

Table 134. PYC Therapeutics Description and Major Businesses

Table 135. PYC Therapeutics Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 136. PYC Therapeutics Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. PYC Therapeutics Recent Developments

Table 138. Asymchem Inc. Company Information

Table 139. Asymchem Inc. Description and Major Businesses

Table 140. Asymchem Inc. Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 141. Asymchem Inc. Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Asymchem Inc. Recent Developments

Table 143. Ajinomoto Company Information

Table 144. Ajinomoto Description and Major Businesses

Table 145. Ajinomoto Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 146. Ajinomoto Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Ajinomoto Recent Developments

Table 148. Sutura Company Information

Table 149. Sutura Description and Major Businesses

Table 150. Sutura Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 151. Sutura Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Sutura Recent Developments

Table 153. Hongene Biotech Company Information

Table 154. Hongene Biotech Description and Major Businesses

Table 155. Hongene Biotech Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 156. Hongene Biotech Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Hongene Biotech Recent Developments

Table 158. Sinopep Company Information

Table 159. Sinopep Description and Major Businesses

Table 160. Sinopep Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 161. Sinopep Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Sinopep Recent Developments

Table 163. Veliter Company Information

Table 164. Veliter Description and Major Businesses

Table 165. Veliter Peptide-PMO Conjugates (PPMO) Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)

Table 166. Veliter Peptide-PMO Conjugates (PPMO) Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Veliter Recent Developments

Table 168. Key Raw Materials Lists

Table 169. Raw Materials Key Suppliers Lists

Table 170. Peptide-PMO Conjugates (PPMO) Distributors List

Table 171. Peptide-PMO Conjugates (PPMO) Customers List

Table 172. Peptide-PMO Conjugates (PPMO) Market Trends

Table 173. Peptide-PMO Conjugates (PPMO) Market Drivers

Table 174. Peptide-PMO Conjugates (PPMO) Market Challenges

Table 175. Peptide-PMO Conjugates (PPMO) Market Restraints

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Peptide-PMO Conjugates (PPMO) Product Picture

Figure 2. Global Peptide-PMO Conjugates (PPMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Peptide-PMO Conjugates (PPMO) Market Share by Type: 2023 & 2030

Figure 4. CPP-PMO Product Picture

Figure 5. Targeting Peptide-PMO Product Picture

Figure 6. Other Product Picture

Figure 7. Global Peptide-PMO Conjugates (PPMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Peptide-PMO Conjugates (PPMO) Market Share by Application: 2023 & 2030

Figure 9. Drug Delivery

Figure 10. Gene Therapy

Figure 11. Other

Figure 12. Peptide-PMO Conjugates (PPMO) Report Years Considered

Figure 13. Global Peptide-PMO Conjugates (PPMO) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 15. Global Peptide-PMO Conjugates (PPMO) Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 16. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Region (2019-2030)

Figure 18. Global Peptide-PMO Conjugates (PPMO) Sales (2019-2030) & (Kg)

Figure 19. Global Peptide-PMO Conjugates (PPMO) Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)

Figure 20. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Peptide-PMO Conjugates (PPMO) Sales YoY (2019-2030) & (Kg)

Figure 22. US & Canada Peptide-PMO Conjugates (PPMO) Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Peptide-PMO Conjugates (PPMO) Sales YoY (2019-2030) & (Kg)

Figure 24. Europe Peptide-PMO Conjugates (PPMO) Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Peptide-PMO Conjugates (PPMO) Sales YoY (2019-2030) & (Kg)

Figure 26. China Peptide-PMO Conjugates (PPMO) Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Peptide-PMO Conjugates (PPMO) Sales YoY (2019-2030) & (Kg)

Figure 28. Asia (excluding China) Peptide-PMO Conjugates (PPMO) Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales YoY (2019-2030) & (Kg)

Figure 30. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Global Peptide-PMO Conjugates (PPMO) Sales Share by Manufacturers (2023)

Figure 32. The Peptide-PMO Conjugates (PPMO) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 33. Global Peptide-PMO Conjugates (PPMO) Revenue Share by Manufacturers (2023)

Figure 34. The Top 5 and 10 Largest Manufacturers of Peptide-PMO Conjugates (PPMO) in the World: Market Share by Peptide-PMO Conjugates (PPMO) Revenue in 2023

Figure 35. Global Peptide-PMO Conjugates (PPMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)

Figure 37. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)

Figure 38. Global Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)

Figure 39. Global Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Peptide-PMO Conjugates (PPMO) Revenue Share by Country (2019-2030)

Figure 45. US & Canada Peptide-PMO Conjugates (PPMO) Sales Share by Country (2019-2030)

Figure 46. US Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)

Figure 49. Europe Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)

Figure 50. Europe Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)

Figure 51. Europe Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)

Figure 52. Europe Peptide-PMO Conjugates (PPMO) Revenue Share by Country (2019-2030)

Figure 53. Europe Peptide-PMO Conjugates (PPMO) Sales Share by Country (2019-2030)

Figure 54. Germany Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 55. France Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 59. China Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)

Figure 60. China Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)

Figure 61. China Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)

Figure 62. China Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)

Figure 63. Asia Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)

Figure 64. Asia Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)

Figure 65. Asia Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)

Figure 66. Asia Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)

Figure 67. Asia Peptide-PMO Conjugates (PPMO) Revenue Share by Region (2019-2030)

Figure 68. Asia Peptide-PMO Conjugates (PPMO) Sales Share by Region (2019-2030)

Figure 69. Japan Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 73. India Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 74. Australia Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 75. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Revenue Share by Country (2019-2030)

Figure 80. Middle East, Africa and Latin America Peptide-PMO Conjugates (PPMO) Sales Share by Country (2019-2030)

Figure 81. Brazil Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 82. Mexico Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 83. Turkey Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 84. Israel Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 85. GCC Countries Peptide-PMO Conjugates (PPMO) Revenue (2019-2030) & (US$ Million)

Figure 86. Peptide-PMO Conjugates (PPMO) Value Chain

Figure 87. Peptide-PMO Conjugates (PPMO) Production Process

Figure 88. Channels of Distribution (Direct Vs Distribution)

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed